top
Please input keywords
OK
홍보센터
Contact us
KR
CN
EN
JP
회사소개
회사소개
회사 연혁
핵심인력
기업문화
사회적 책임
인재모집
합작연구개발
Collaborations
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
동물/세포 모델
Humanized animal models
KO mouse models
Tool mice
Immunodeficient mice/rats
Cell lines
Aged mice
Disease mouse models
Pharmacology service
Therapeutic area
Types of services
Molecule type
Technology
유전자 편집
By species
By technologies
By strategies
Animal Breeding
Animal Cryopreservation
Animal Rederivation
Other Services
Microbial detection
Animal Breeding
Animal Cryopreservation
Animal Rederivation
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
News events
자료 다운로드
포스터 다운로드
홍보센터
뉴스 및 각종 자료 열람
뉴스
공지사항
웨비나
논문게재실적
자료 다운로드
포스터 다운로드
제품정보 다운로드
2025
AACR 2025: Preclinical syngeneic model and xenograft model for evaluating CD3/HER2 bispecific antibody therapy
2025
AACR 2025: A novel humanized IL2 and IL15 receptor mouse model enables preclinical efficacy studies for IL-2 cancer therapeutics
2025
AACR 2025:Development and validation of a novel humanized B-hTRBC1/hTRBC2 mouse model for T cell activation
2025
AACR 2025: Utilizing a humanized HLA-A2.1 mouse model for non-clinical studies of mRNA vaccines
2025
AACR 2025: An in vivo humanized mouse model for human dendritic cell reconstitution to evaluate efficacy of tumor immunotherapy by B-NDG Flt3 KO mice
2025
AACR 2025: The humanized CRBN mice model facilitates PROTACs studies based on CRBN ligands
2024
SITC2024: TAA antibody library and novel linker/payload BLD1102 for ADC, bispecific ADC and nanobody-drug conjugate development
2024
SITC 2024: Establishing a tumor cell model to evaluate the bystander effect of antibody-drug conjugate (ADC) therapies
2024
SITC 2024: A novel IL12Rβ1 and IL12Rβ2 humanized mouse model for preclinical efficacy and toxicity evaluation of human IL-12 analogs
1
2
3
4
5
…
14
GO